IGF1R and adrenal cortex carcinoma: Up to now, different molecular targeted therapies have been tested against ACC, including treatments targeting epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF), multityrosine kinases, or the insulin-like growth factor 1 receptor (IGF-1R) inhibitor.